Key result
While intracranial atherosclerotic disease carries a high recurrence risk, current evidence indicates that endovascular stenting should be reserved for select patients refractory to aggressive medical therapy.
Why the study?
Intracranial atherosclerotic disease pathophysiology and treatment require detailed understanding due to its distinct progression and high incidence in Asian populations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yasushi Takagi (2021) conducted a review in Intracranial Atherosclerotic Disease. Endovascular stenting and surgical treatment vs. Aggressive medical therapy was evaluated. While intracranial atherosclerotic disease carries a high recurrence risk, current evidence indicates that endovascular stenting should be reserved for select patients refractory to aggressive medical therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: